Article PDF
References
Porter, P.L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222–225 (1997).
Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231–234 (1997).
Catzavelos, C. et al. Decreased levels of the cell-cycle inhibitor p27Klpl protein: Prognostic implications in primary breast cancer. Nature Med. 3, 227–230 (1997).
Steeg, P.S. & Abrams, J.S. Cancer prognostics: Past, present and p27. Nature Med. 3, 152–154 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mori, M., Mimori, K., Shiraishi, T. et al. p27 expression and gastric carcinoma. Nat Med 3, 593 (1997). https://doi.org/10.1038/nm0697-593
Issue Date:
DOI: https://doi.org/10.1038/nm0697-593
This article is cited by
-
Bacterial protein MakA causes suppression of tumour cell proliferation via inhibition of PIP5K1α/Akt signalling
Cell Death & Disease (2022)
-
Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis
Molecular Cancer (2018)
-
A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma
Journal of Gastroenterology (2014)
-
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma
Endocrine (2013)
-
The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation
Medical Oncology (2013)